Nanoscope in the News
-
CGT Live: 10 Cell and Gene Therapies to Watch in 2023
January 25, 2023 by Nanoscope Therapeutics
-
Modern Retina: FDA grants fast track designation to Nanoscope Therapeutics for MCO-010 for the treatment of retinitis pigmentosa
October 18, 2022 by Nanoscope Therapeutics
-
Ocular Surgery News: Retinitis Pigmentosa Treatment Receives Fast Track Designation
October 18, 2022 by Nanoscope Therapeutics
-
Euretina Congress Daily: Making Headway in the Battle Against Inherited Retinal Disease
September 15, 2022 by Nanoscope Therapeutics
-
Ophthalmology Times: Enrollment Complete in STARLIGHT Phase 2 Clinical Trial of MCO-010 Optogenetic Gene Therapy for Stargardt Disease
September 13, 2022 by Nanoscope Therapeutics
-
Meet the 43 Finalists for the 2022 Tech Titans Awards
September 9, 2022 by Nanoscope Therapeutics
-
CityBiz: TechFW Member Nanoscope Starts Second Stage 2 Trial
July 26, 2022 by Nanoscope Therapeutics
-
CGT Live: Nanoscope Gene Therapy Continues Progress in Stargardt Disease
July 26, 2022 by Nanoscope Therapeutics
-
Ocular Surgery News: Phase 2 gene therapy trial for Stargardt disease underway
July 26, 2022 by Wilson PJ
-
Ophthalmology Times: Nanoscope Therapeutics announces first patient dosed in STARLIGHT Phase 2 clinical trial of MCO-010 optogenetic gene therapy for Stargardt disease
July 25, 2022 by Nanoscope Therapeutics
-
Retina Synthesis: Optogenetics Interview with Samarendra Mohanty, PhD and Charles Wykoff, MD
May 3, 2022 by Nanoscope Therapeutics
-
Healio: Gene therapy platform for Stargardt macular degeneration receives IND clearance
January 25, 2022 by Nanoscope Therapeutics
-
Ophthalmology Times: Nanoscope Therapeutics announces FDA clearance of IND for MCO-010 gene therapy in Stargardt patients
January 25, 2022 by Nanoscope Therapeutics
-
Photonics West BIOS Show Daily: Optogenetics a Promising Route to Vision Restoration
January 22, 2022 by Nanoscope Therapeutics
-
Ft Worth Business Press: TechFW Client Nanoscope Receives $1.5M Grant to Move Macular Degeneration Therapy Forward
September 21, 2021 by Nanoscope Therapeutics
-
Dallas Innovates: Nanoscope Awarded $1.5 Million Grant for Eyesight Gene Therapy as it ‘Takes Steps to Go Public’
September 17, 2021 by Nanoscope Therapeutics
-
Journal of Cellular and Molecular Medicine: Biodistribution of adeno-associated virus type 2 carrying multi-characteristic opsin in dogs following intravitreal injection
August 23, 2021 by Nanoscope Therapeutics
-
The Science Advisory Board: Optogenetic gene therapy provides hope for retinitis pigmentosa patients
August 6, 2021 by Nanoscope Therapeutics
-
Fort Worth Business Press: First patient receives innovative gene therapy eye treatment from TechFW client
August 4, 2021 by Nanoscope Therapeutics
-
Retina Today: AAV Gene Therapy Trials to Watch
August 3, 2021 by Nanoscope Therapeutics